REG - BkofA Merrill Lynch Avadel Pharma plc - Form 8.3-Avadel Pharmaceuticals plc

RNS Number : 3095M Bank of America Merrill Lynch 19 December 2025 FORM 8.3IRISH TAKEOVER PANELOPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVERRULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE1. KEY INFORMATION(a) Full name of discloserBank of America Corporation(b) Owner or controller of interests and short positions disclosed, if different from 1(a)The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.(c) Name of offeror/offeree in relation to whose relevant securities this form relatesUse a separate form for each offeror/offereeAVADEL PHARMACEUTICALS PLC(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree (Note 1)(e) Date position held/dealing undertakenFor an opening position disclosure, state the latest practicable date prior to the disclosure18/12/2025(f) In addition to the company in 1(c) above, is the discloser also making disclosures in respect of any other party to the offer?If it is a cash offer or possible cash offer, state "N/A"No2. INTERESTS AND SHORT POSITIONSIf there are interests and short positions to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2 for each additional class of relevant security.Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)(Note 2)Class of relevant security (Note 3)0.01 ordinary sharesInterestsShort positionsNumber%Number%(1) Relevant securities owned and/or controlled1,768,1361.815%515,1930.529%(2) Cash-settled derivatives427,1860.439%473,8730.487%(3) Stock-settled derivatives (including options) and agreements to purchase/ sell00.000%00.000%Total2,195,3222.254%989,0661.016%All interests and all short positions should be disclosed.Details of options including rights to subscribe for new securities and any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8.3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE (Note 4)Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.The currency of all prices and other monetary amounts should be stated.(a) Purchases and salesClass of relevantsecurityPurchase/saleNumber ofsecuritiesPrice per unit (Note 5)USD 0.01 commonPurchase1821.385 USDUSD 0.01 commonPurchase11521.39 USDUSD 0.01 commonPurchase1721.394118 USDUSD 0.01 commonPurchase3621.395 USDUSD 0.01 commonPurchase721.395715 USDUSD 0.01 commonPurchase2821.397858 USDUSD 0.01 commonPurchase2721.39963 USDUSD 0.01 commonPurchase92221.4 USDUSD 0.01 commonPurchase2821.400715 USDUSD 0.01 commonPurchase4721.401277 USDUSD 0.01 commonPurchase7421.401757 USDUSD 0.01 commonPurchase1721.401765 USDUSD 0.01 commonPurchase7321.401781 USDUSD 0.01 commonPurchase27421.401789 USDUSD 0.01 commonPurchase9521.40179 USDUSD 0.01 commonPurchase53121.401808 USDUSD 0.01 commonPurchase4221.401905 USDUSD 0.01 commonPurchase1321.402308 USDUSD 0.01 commonPurchase3121.402581 USDUSD 0.01 commonPurchase1421.402858 USDUSD 0.01 commonPurchase2721.402963 USDUSD 0.01 commonPurchase1621.404375 USDUSD 0.01 commonPurchase2221.404546 USDUSD 0.01 commonPurchase1921.404737 USDUSD 0.01 commonPurchase2321.404783 USDUSD 0.01 commonPurchase19021.405 USDUSD 0.01 commonPurchase1721.405295 USDUSD 0.01 commonPurchase4421.405682 USDUSD 0.01 commonPurchase1421.405715 USDUSD 0.01 commonPurchase1721.405883 USDUSD 0.01 commonPurchase3621.406112 USDUSD 0.01 commonPurchase3421.406177 USDUSD 0.01 commonPurchase4821.40625 USDUSD 0.01 commonPurchase2021.4065 USDUSD 0.01 commonPurchase1521.406667 USDUSD 0.01 commonPurchase1621.409375 USDUSD 0.01 commonPurchase13621.41 USDUSD 0.01 commonPurchase1521.414667 USDUSD 0.01 commonPurchase3421.415 USDUSD 0.01 commonPurchase1921.415264 USDUSD 0.01 commonPurchase2421.41875 USDUSD 0.01 commonPurchase4421.419091 USDUSD 0.01 commonPurchase1921.419474 USDUSD 0.01 commonPurchase2021.4195 USDUSD 0.01 commonPurchase54021.42 USDUSD 0.01 commonPurchase14221.44 USDUSD 0.01 commonPurchase921.445556 USDUSD 0.01 commonPurchase421.45 USDUSD 0.01 commonPurchase621.453334 USDUSD 0.01 commonPurchase4,38521.42 USD Class of relevantsecurityPurchase/saleNumber ofsecuritiesPrice per unit (Note 5)USD 0.01 commonSale1821.395 USDUSD 0.01 commonSale33021.4 USDUSD 0.01 commonSale7421.401757 USDUSD 0.01 commonSale7321.401781 USDUSD 0.01 commonSale27421.401789 USDUSD 0.01 commonSale9521.40179 USDUSD 0.01 commonSale53121.401808 USDUSD 0.01 commonSale3421.405 USDUSD 0.01 commonSale521.406 USDUSD 0.01 commonSale321.406667 USDUSD 0.01 commonSale22721.41 USDUSD 0.01 commonSale221.415 USDUSD 0.01 commonSale721.415715 USDUSD 0.01 commonSale3,50521.416 USDUSD 0.01 commonSale321.416667 USDUSD 0.01 commonSale43921.42 USDUSD 0.01 commonSale2821.425 USDUSD 0.01 commonSale2621.425385 USDUSD 0.01 commonSale1121.425455 USDUSD 0.01 commonSale521.426 USDUSD 0.01 commonSale321.426667 USDUSD 0.01 commonSale1321.43 USDUSD 0.01 commonSale3921.44 USDUSD 0.01 commonSale8221.45 USDUSD 0.01 commonSale8621.42 USD (b) Cash-settled derivative transactionsClass of relevant securityProduct description e.g. CFDNature of dealing e.g. opening/ closing a long/ short position, increasing/ reducing a long/ short positionNumber of reference securities (Note 6)Price per unit (Note 5) USDUSD 0.01 commonSwapsOpening a long position4821.4198 USDUSD 0.01 commonSwapsIncreasing a long position15821.3998 USDUSD 0.01 commonSwapsIncreasing a long position1421.42 USDUSD 0.01 commonSwapsIncreasing a long position350521.4158 USD(c) Stock-settled derivative transactions (including options)(i) Writing, selling, purchasing or varyingClass of relevant securityN/AProduct description e.g. call optionN/AWriting, purchasing, selling, varying etc.N/ANumber of securities to which option relates (Note 6)N/AExerciseprice per unitN/AType e.g. American, Europeanetc.N/AExpiry dateN/AOption moneypaid/ received per unitN/A(ii) ExerciseClass of relevant securityN/AProduct description e.g. call optionN/AExercising/ exercised againstN/ANumber of securitiesN/AExercise price per unit (Note 5)N/A(d) Other dealings (including transactions in respect of new securities) (Note 3)Class of relevant securityN/ANature of dealing e.g. subscription, conversion, exerciseN/ADetailsN/APrice per unit (if applicable) (Note 5)N/A4. OTHER INFORMATION(a) Indemnity and other dealing arrangementsDetails of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer.Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"(b) Agreements, arrangements or understandings relating to options or derivativesFull details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.(c) AttachmentsIs a Supplemental Form 8 attached?NoDate of disclosure19/12/2025Contact nameKamil DziedzicTelephone number+353 86 168 4821Public disclosures under Rule 8.3 of the Rules must be made to a Regulatory Information Service.This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. END ITPFLFSIFALALIE